Incyte Corporation
Stock Details
Is it expensive?
Trailing P/E Ratio
14.60
Forward P/E Ratio
10.82
PEG Ratio
0.32
10.66
Price-to-Sales (TTM)
3.62
3.59
26.04
Market Cap
18.65B
15.35B
Is it profitable?
Net Profit Margin (TTM)
25.03%
Gross Profit Margin
91.96%
Diluted EPS (TTM)
6.41
29.87%
5.14B
Is it growing?
27.80%
48.70%
Is it risky?
0.86
1.06
3.32
54.92M
Who owns it?
105.32%
1.87%
7.78%
198.46M
166.62M
Does it pay?
0.00%
0.00%
--
--
How much cash?
3.58B
1.41B
609.55M
17.99
- Price
- 95.89
- Percent Change
- +2.20 (2.35%)
- Previous Close
- 93.69
- Open
- 95.62
- Low
- 93.56
- High
- 95.77
52-Week Range Position (52WRP)
Above Average
Above Average
within its 1-year price range
$95.89
From 52W Low
+79.03%
From 52W High
-14.61%
Today
+2.35%
1Y Change
+62.91%
6M
$84.75
3M
$106.87
1M
$97.10
Today
$95.89
From 52W Low
+79.03%
From 52W High
-14.61%
Today
+2.35%
1Y Change
+62.91%
6M
$84.75
3M
$106.87
1M
$97.10
Today
$95.89
Above Average
within its 1-year price range
$95.89
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-1.2%
3M
-10.3%
6M
+13.1%
1Y
+62.9%
Rate of Change (ROC)
Decelerating
Price has reversed, now falling vs its usual uptrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Incyte Corporation
- Founded
- Jan 1, 1991
- Founders
- Randy Scott
- CEO
- William J. Meury
- Employees
- 2,844
- Fiscal Year End
- Dec 31, 2025
- Address
1801 Augustine Cut-off
Wilmington
Delaware
19803
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.incyte.com
Indicators
Operating Cash Flow
1.41B
Net Income
1.29B
Backed by Cash
1.10
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Indicators
Operating Cash Flow
1.41B
Net Income
1.29B
Backed by Cash
1.10
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
14.60
Forward P/E Ratio
10.82
PEG Ratio
0.32
10.66
Price-to-Sales (TTM)
3.62
3.59
26.04
Market Cap
18.65B
15.35B
Is it profitable?
Net Profit Margin (TTM)
25.03%
Gross Profit Margin
91.96%
Diluted EPS (TTM)
6.41
29.87%
5.14B
Is it growing?
27.80%
48.70%
Is it risky?
0.86
1.06
3.32
54.92M
Who owns it?
105.32%
1.87%
7.78%
198.46M
166.62M
Does it pay?
0.00%
0.00%
--
--
How much cash?
3.58B
1.41B
609.55M
17.99
- Price
- 95.89
- Percent Change
- +2.20 (2.35%)
- Previous Close
- 93.69
- Open
- 95.62
- Low
- 93.56
- High
- 95.77
52-Week Range Position (52WRP)
Above Average
Above Average
within its 1-year price range
$95.89
From 52W Low
+79.03%
From 52W High
-14.61%
Today
+2.35%
1Y Change
+62.91%
6M
$84.75
3M
$106.87
1M
$97.10
Today
$95.89
From 52W Low
+79.03%
From 52W High
-14.61%
Today
+2.35%
1Y Change
+62.91%
6M
$84.75
3M
$106.87
1M
$97.10
Today
$95.89
Above Average
within its 1-year price range
$95.89
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-1.2%
3M
-10.3%
6M
+13.1%
1Y
+62.9%
Rate of Change (ROC)
Decelerating
Price has reversed, now falling vs its usual uptrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Incyte Corporation
- Founded
- Jan 1, 1991
- Founders
- Randy Scott
- CEO
- William J. Meury
- Employees
- 2,844
- Fiscal Year End
- Dec 31, 2025
- Address
1801 Augustine Cut-off
Wilmington
Delaware
19803
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.incyte.com